• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    COMPASS Pathways Plc - American Depository Shares (NQ:CMPS)

    7.630 +1.820 (+31.33%)
    Streaming Delayed Price Updated: 4:00 PM EST, Feb 17, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 34,970,499
    Open 7.830
    Bid (Size) 7.210 (700)
    Ask (Size) 7.240 (100)
    Prev. Close 5.810
    Today's Range 7.310 - 8.795
    52wk Range 2.250 - 8.200
    Shares Outstanding 41,695,335
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Compass Pathways Launches Proposed $150.0 Million Public Offering
    From Compass Pathfinder Limited
    Via Business Wire
    Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗
    Via Chartmill

    Performance

    YTD
    +16.5%
    +16.5%
    1 Month
    +4.4%
    +4.4%
    3 Month
    +43.2%
    +43.2%
    6 Month
    +79.1%
    +79.1%
    1 Year
    +72.2%
    +72.2%

    More News

    Read More
    News headline image
    Why Did Compass Pathways Stock Rocket Higher Today? ↗
    Via The Motley Fool
    Tuesday's session: gap up and gap down stocks ↗
    Via Chartmill
    CMPS Stock Climbs 5% In Premarket After FDA Clears PTSD Trial Path ↗
    Via Stocktwits
    News headline image
    Earnings Scheduled For November 4, 2025 ↗
    Via Benzinga
    Tuesday's pre-market session: top gainers and losers ↗
    Via Chartmill
    News headline image
    Compass Pathways Successfully Achieves Primary Endpoint in Second Phase 3 Trial Evaluating COMP360 Psilocybin for Treatment-Resistant Depression
    From Compass Pathfinder Limited
    Via Business Wire
    News headline image
    CMPS Stock Rises 23% Pre-Market As Compass Achieves Primary Endpoint In Phase 3 Treatment-Resistant Depression Trial ↗
    Via Stocktwits
    News headline image
    CMPS Stock Jumps 22% Pre-Market As Compass Sets Timeline For New Phase 3 Depression Trial Results ↗
    Via Stocktwits
    News headline image
    Compass Pathways to Announce New Clinical Data from Two Ongoing Phase 3 Trials
    From Compass Pathfinder Limited
    Via Business Wire
    News headline image
    Compass Pathways Announces FDA Acceptance of IND Application for PTSD and Hosts Webinar on PTSD and TRD
    From Compass Pathfinder Limited
    Via Business Wire
    News headline image
    Compass Pathways Establishes Strategic Collaboration with Radial to Innovate Patient Experience and Inform Potential Delivery Model of COMP360
    From Compass Pathfinder Limited
    Via Business Wire
    News headline image
    Psychedelics Break Out Of The Fringe Under RFK Jr’s 2025 Reset — But Did MNMD Or CMPS Own The Year? ↗
    Via Stocktwits
    Topics ETFs
    News headline image
    Compass Pathways to Host Webinar on Commercial Preparations for Treatment-Resistant Depression (TRD) and Clinical Trial Plans for Post-Traumatic Stress Disorder (PTSD) on January 7, 2026, 10:00am ET
    From Compass Pathfinder Limited
    Via Business Wire
    News headline image
    Compass Pathways to Participate in Two Investor Conferences in December
    From Compass Pathfinder Limited
    Via Business Wire
    News headline image
    Compass Pathways to Participate in Stifel 2025 Healthcare Conference
    From Compass Pathfinder Limited
    Via Business Wire
    News headline image
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Compass Pathways Announces Third Quarter 2025 Financial Results and Business Highlights Including Acceleration of Commercial Launch Plans by 9-12 Months
    From Compass Pathfinder Limited
    Via Business Wire
    News headline image
    Compass Pathways Appoints Dr. Jeffrey Jonas to Board of Directors
    From Compass Pathfinder Limited
    Via Business Wire
    News headline image
    Compass Pathways to Announce Third Quarter Financial Results on November 4, 2025
    From Compass Pathfinder Limited
    Via Business Wire
    News headline image
    Design Therapeutics Appoints Justin Gover to Board of Directors
    From Design Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Compass Pathways Announces Publication of Results from Phase 2 Study of COMP360 Psilocybin for Post-Traumatic Stress Disorder
    From Compass Pathfinder Limited
    Via Business Wire
    News headline image
    Compass Pathways to Participate in Four Investor Conferences in September
    From Compass Pathfinder Limited
    Via Business Wire
    News headline image
    Compass Pathways to Participate in Canaccord Genuity 45th Annual Growth Conference on August 12, 2025 in Boston, MA
    From Compass Pathfinder Limited
    Via Business Wire

    Frequently Asked Questions

    Is COMPASS Pathways Plc - American Depository Shares publicly traded?
    Yes, COMPASS Pathways Plc - American Depository Shares is publicly traded.
    What exchange does COMPASS Pathways Plc - American Depository Shares trade on?
    COMPASS Pathways Plc - American Depository Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for COMPASS Pathways Plc - American Depository Shares?
    The ticker symbol for COMPASS Pathways Plc - American Depository Shares is CMPS on the Nasdaq Stock Market
    What is the current price of COMPASS Pathways Plc - American Depository Shares?
    The current price of COMPASS Pathways Plc - American Depository Shares is 7.630
    When was COMPASS Pathways Plc - American Depository Shares last traded?
    The last trade of COMPASS Pathways Plc - American Depository Shares was at 02/17/26 04:00 PM ET
    What is the market capitalization of COMPASS Pathways Plc - American Depository Shares?
    The market capitalization of COMPASS Pathways Plc - American Depository Shares is 318.14M
    How many shares of COMPASS Pathways Plc - American Depository Shares are outstanding?
    COMPASS Pathways Plc - American Depository Shares has 318M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.